Targeting of tracked tumor foci ups gleason score upgrading

Targeting of tracked tumor foci ups gleason score upgrading

(HealthDay)—Targeting of tracked tumor foci allows for improved detection of Gleason score 4 + 3 or greater cancers among men under active surveillance for prostate cancer, according to a study published in the March issue of The Journal of Urology.

Nima Nassiri, M.D., from the University of California in Los Angeles, and colleagues examined the rate of upgrading to Gleason score 4 + 3 or greater in 259 patients who were diagnosed via (MRI)/ultrasound fusion guided biopsy from 2009 to 2015 and underwent fusion biopsy during active surveillance.

The researchers found that men with Gleason score 3 + 4 were 4.65 times more likely to have upgrading at three years than men with Gleason score of 3 + 3 (P < 0.01). By the third surveillance year, 63 and 18.0 percent of men with Gleason score 3 + 4 and 3 + 3, respectively, had been upgraded (P < 0.01). Ninety-seven percent of the 33 upgrades occurred at a MRI-visible or a tracked site of tumor, instead of a previously negative systematic site. Gleason score 3 + 4, prostate-specific antigen density 0.15 ng/ml/cm³ or greater, and a grade 5 lesion on MRI were independent predictors of upgrading.

"During of prostate cancer, targeting of tracked tumor foci by MRI/ultrasound fusion biopsy allows for heightened detection of Gleason score 4 + 3 or greater cancers," the authors write.


Explore further

Less intense surveillance OK for some prostate cancer cases

More information: Abstract
Full Text
Journal information: Journal of Urology

Copyright © 2017 HealthDay. All rights reserved.

Citation: Targeting of tracked tumor foci ups gleason score upgrading (2017, February 23) retrieved 21 July 2019 from https://medicalxpress.com/news/2017-02-tracked-tumor-foci-ups-gleason.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more